Cypress Capital Group Has $5.23 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Cypress Capital Group boosted its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 5.5% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 10,277 shares of the healthcare conglomerate’s stock after buying an additional 533 shares during the quarter. Cypress Capital Group’s holdings in UnitedHealth Group were worth $5,234,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. International Assets Investment Management LLC raised its position in UnitedHealth Group by 1.9% in the fourth quarter. International Assets Investment Management LLC now owns 4,468 shares of the healthcare conglomerate’s stock valued at $2,352,000 after purchasing an additional 85 shares during the last quarter. GUNN & Co INVESTMENT MANAGEMENT INC. raised its position in shares of UnitedHealth Group by 1,337.3% during the fourth quarter. GUNN & Co INVESTMENT MANAGEMENT INC. now owns 97,679 shares of the healthcare conglomerate’s stock worth $51,425,000 after acquiring an additional 90,883 shares during the last quarter. Linden Thomas Advisory Services LLC raised its position in shares of UnitedHealth Group by 25.9% during the fourth quarter. Linden Thomas Advisory Services LLC now owns 2,219 shares of the healthcare conglomerate’s stock worth $1,168,000 after acquiring an additional 456 shares during the last quarter. BIP Wealth LLC raised its position in shares of UnitedHealth Group by 51.1% during the fourth quarter. BIP Wealth LLC now owns 621 shares of the healthcare conglomerate’s stock worth $327,000 after acquiring an additional 210 shares during the last quarter. Finally, VCI Wealth Management LLC bought a new position in shares of UnitedHealth Group during the fourth quarter worth about $970,000. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Stock Performance

Shares of UNH traded up $5.79 during mid-day trading on Friday, hitting $584.51. The stock had a trading volume of 2,376,416 shares, compared to its average volume of 3,156,778. The firm has a market cap of $539.75 billion, a P/E ratio of 35.73, a PEG ratio of 1.61 and a beta of 0.59. The business has a fifty day moving average price of $537.83 and a 200-day moving average price of $509.89. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.88 and a quick ratio of 0.88. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $591.54.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.66 by $0.14. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The company had revenue of $98.86 billion for the quarter, compared to analyst estimates of $98.73 billion. During the same period in the previous year, the company posted $6.14 EPS. The firm’s revenue for the quarter was up 6.4% compared to the same quarter last year. On average, equities research analysts expect that UnitedHealth Group Incorporated will post 27.69 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th will be issued a $2.10 dividend. The ex-dividend date is Monday, September 16th. This represents a $8.40 annualized dividend and a dividend yield of 1.44%. UnitedHealth Group’s payout ratio is currently 51.34%.

Analysts Set New Price Targets

Several equities research analysts recently commented on UNH shares. JPMorgan Chase & Co. raised their target price on UnitedHealth Group from $546.00 to $559.00 and gave the stock an “overweight” rating in a research note on Thursday, May 30th. UBS Group raised their target price on UnitedHealth Group from $640.00 to $680.00 and gave the stock a “buy” rating in a research note on Thursday, July 18th. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Wednesday. TD Cowen raised their price objective on UnitedHealth Group from $546.00 to $601.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. Finally, Barclays raised their price objective on UnitedHealth Group from $560.00 to $604.00 and gave the company an “overweight” rating in a research note on Wednesday, July 17th. One equities research analyst has rated the stock with a hold rating, nineteen have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus target price of $614.17.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the sale, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In related news, EVP Erin Mcsweeney sold 1,500 shares of the firm’s stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the transaction, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the transaction, the chief accounting officer now directly owns 29,501 shares in the company, valued at $16,812,029.88. The disclosure for this sale can be found here. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.